• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions

  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • expand A RANDOMISED, MULTICENTRE, PHASE II, PARALLEL-GROUP TRIAL OF VANDETANIB MONOTHERAPY OR VANDETANIB IN COMBINATION WITH GEMCITABINE VERSUS GEMCITABINE PLUS VANDETANIB MATCHING PLACEBO IN SUBJECTS WITH ADVANCED BILIARY TRACT CANCER (GALLBLADDER CANCER, CANCER OF THE EXTRAHEPATIC BILE DUCT, INTRAHEPATIC
    Study Id
    D4200L00007
    Disease
    solid tumour
    Drug Name
    Caprelsa
    Study Name
    D4200L00007
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Open Label Prostate Cancer Study in Japanese Patients
    Study Id
    D3760C00003
    Disease
    prostate cancer
    Study Name
    D3760C00003
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
    Study Id
    D5890C00017
    Disease
    asthma
    Drug Name
    Symbicort
    Study Name
    D5890C00017
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Aug 12, 2011
    • D5890C00017.pdf (117 KB)
  • expand Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
    Study Id
    D6997L00021
    Disease
    breast cancer
    Drug Name
    Faslodex
    Study Name
    D6997L00021
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
    Study Id
    D2610C00003
    Disease
    breast cancer
    Drug Name
    AZD4547
    Study Name
    D2610C00003
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
    Study Id
    D2270C00001
    Disease
    solid tumour
    Drug Name
    AZD2014
    Study Name
    D2270C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
    Study Id
    D2340C00003
    Drug Name
    AZD5423
    Study Name
    D2340C00003
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
    Study Id
    NIS-OHU-ZOL-2007-1
    Disease
    prostate cancer
    Drug Name
    Zoladex
    Study Name
    NIS-OHU-ZOL/2007/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Jun 15, 2011
    • NIS-OHU-ZOL-2007/1.pdf (91 KB)
  • expand Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
    Study Id
    D0910C00015
    Disease
    infection
    Drug Name
    AZD5099
    Study Name
    D0910C00015
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
    Study Id
    NIS-MENA-SA-IRS-2010/01
    Drug Name
    non drug study (oncology)
    Study Name
    NIS-MENA-SA-IRS-2010/01
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013